Benign Conditions

Sulopenem hits key end point in phase 3 uncomplicated UTI trial

June 29, 2020

The novel oral penem anti-infective compound sulopenem showed stronger clinical activity than ciprofloxacin in patients with uncomplicated urinary tract infections with quinolone resistant pathogens, according to findings from the phase 3 SURE1 trial.

Minimally invasive treatments grab BPH spotlight

January 30, 2019

Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.

TURP duration linked with complication rate

November 20, 2018

Procedure safest when performed in